RE: Moving Up π₯24 Mar 2025 14:51
Shareholder register shows BoD has significant skin in the game especially SW. Recent appointment of Dr Disley cannot be ignored as he was previously a director of Oncogeni. Short term issues such as churn of placing shares cannot override the positives here and minimal downside. We will see the sp rerate in short term regardless of all the background noise.